Bermekimab (MABp1) is a humanized monoclonal antibody against interleukin-1alpha (IL-1alpha).Bermekimab has potential anti-inflammatory activity to prevent skin inflammation.
Purity:
97.80%
CAS Number:
[1401965-15-8]
Target:
Interleukin|||IL Receptor
T76777
T76777
* VAT and and shipping costs not included. Errors and price changes excepted
